Breaking News Instant updates and real-time market news.

2021-01-24 14:55:26 AUPH Aurinia Pharmaceuticals $14.86 / -0.335 (-2.20%) 14:55 01/24/21 01/24 14:55 01/24/21 14:55	FDA approves Aurinia's LUPKYNIS for adult patients with active lupus nephritis Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration has approved LUPKYNISTM in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis. LUPKYNIS is the first FDA-approved oral therapy for LN. In pivotal trials, patients treated with LUPKYNIS in combination with standard-of-care were more than twice as likely to achieve renal response and experienced a decline in urine protein creatinine ratio twice as fast as patients on typical SoC alone. Patients treated with LUPKYNIS showed improved response rates in all parameters across immunologically-active classes of LN studied. LUPKYNIS was approved by the FDA under Priority Review and was previously granted Fast Track designation from the Agency in 2016.	01 Mar 23 Jul
AUPH Aurinia Pharmaceuticals $14.86 / -0.335 (-2.20%) 12/18/20 H.C. Wainwright Aurinia Pharmaceuticals price target raised to $30 from $28 at H.C. Wainwright 12/04/20 Cowen Cowen calls Aurinia a best idea for 2021 into FDA action date 11/12/20 Cantor Fitzgerald Aurinia Pharmaceuticals price target lowered to $26 from $30 at Cantor Fitzgerald 11/03/20 H.C. Wainwright Aurinia Pharmaceuticals price target lowered to $28 from $34 at H.C. Wainwright

2021-01-24 14:55:26

AUPH

Aurinia Pharmaceuticals

$14.86 / -0.335 (-2.20%)

14:55

01/24/21

01/24

14:55

01/24/21

14:55

FDA approves Aurinia's LUPKYNIS for adult patients with active lupus nephritis

Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration has approved LUPKYNISTM in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis. LUPKYNIS is the first FDA-approved oral therapy for LN. In pivotal trials, patients treated with LUPKYNIS in combination with standard-of-care were more than twice as likely to achieve renal response and experienced a decline in urine protein creatinine ratio twice as fast as patients on typical SoC alone. Patients treated with LUPKYNIS showed improved response rates in all parameters across immunologically-active classes of LN studied. LUPKYNIS was approved by the FDA under Priority Review and was previously granted Fast Track designation from the Agency in 2016.

01
Mar

23
Jul

AUPH Aurinia Pharmaceuticals

$14.86 / -0.335 (-2.20%)

12/18/20 H.C. Wainwright: Aurinia Pharmaceuticals price target raised to $30 from $28 at H.C. Wainwright

12/04/20 Cowen: Cowen calls Aurinia a best idea for 2021 into FDA action date

11/12/20 Cantor Fitzgerald: Aurinia Pharmaceuticals price target lowered to $26 from $30 at Cantor Fitzgerald

11/03/20 H.C. Wainwright: Aurinia Pharmaceuticals price target lowered to $28 from $34 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Conference/Events	Wells Fargo to hold a virtual conference » 10:36 03/04/21 03/04 10:36 03/04/21 10:36 ACN Accenture $251.34 / -3.09 (-1.21%) , BAC Bank of America $36.40 / +0.34 (+0.94%) , JKHY Jack Henry $150.47 / -1.78 (-1.17%) , KEY KeyCorp $20.38 / -0.25 (-1.21%) , QTWO Q2 Holdings $109.35 / -4.62 (-4.05%) , SBNY Signature Bank $215.40 / -6.46 (-2.91%) , SFNC Simmons First National $31.25 / +0.42 (+1.36%) , SNV Synovus $43.99 / -0.2 (-0.45%) , TBK Triumph Bancorp $83.90 / +2.28 (+2.79%) , TD Toronto-Dominion $62.28 / -0.13 (-0.21%) , USB U.S. Bancorp $51.00 / -0.16 (-0.31%) Bank and Tech Pop Up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ACN BAC JKHY KEY QTWO SBNY SFNC SNV TBK TD USB ACN Accenture $251.34 / -3.09 (-1.21%) 03/03/21 Accenture acquires REPL Group; terms not disclosed 03/01/21 Pros Holdings names Katrina Klier Chief Marketing Officer 03/01/21 Accenture to acquire Pollux, terms undisclosed 03/01/21 Accenture acquires Cirrus, terms undisclosed BAC Bank of America $36.40 / +0.34 (+0.94%) 02/26/21 Bank of America sees corporate loan activity picking up in 2H 02/26/21 Bank of America: Q1 NII may be lower vs. Q4 02/26/21 Bank of America 'constructive' on economy 02/21/21 Fly Intel: Top five weekend stock stories JKHY Jack Henry $150.47 / -1.78 (-1.17%) 02/16/21 Jack Henry raises dividend 7% to 46c 10/02/20 CSPI to acquire CruiseNet core from Jack Henry KEY KeyCorp $20.38 / -0.25 (-1.21%) 01/26/21 KeyCorp rises -0.9% 01/26/21 KeyCorp rises 0.2% 01/21/21 KeyCorp sees long-term ROTCE 16%-19%, cash efficiency ratio 54%-56% 01/21/21 KeyCorp sees FY21 NII relatively stable, including ongoing PPP participation QTWO Q2 Holdings $109.35 / -4.62 (-4.05%) 12/07/20 Q2 Holdings names Carlos Carvajal chief marketing officer 11/04/20 Q2 Holdings names David Mehok CFO SBNY Signature Bank $215.40 / -6.46 (-2.91%) 12/17/20 Signature names Lisa Bond chief corporate social impact officer, Ana Harris CHRO SFNC Simmons First National $31.25 / +0.42 (+1.36%) 03/03/21 Simmons First National appoints Julie Stackhouse to board of directors 10/22/20 Simmons First National resumes stock repurchase program SNV Synovus $43.99 / -0.2 (-0.45%) 01/26/21 Synovus reports Q4 net interest margin 3.12%, up 2 bps vs. Q3 01/26/21 Synovus says Kevin Blair will become CEO in April 11/22/20 Fly Intel: Top five weekend stock stories TBK Triumph Bancorp $83.90 / +2.28 (+2.79%) 01/26/21 Triumph Bancorp's TriumphPay appoints Ed Schreyer as COO 10/13/20 Redwood Logistics announces partnership with TriumphPay 09/23/20 Covenant Logistics resolves TFS division sale dispute with Triumph Bancorp TD Toronto-Dominion $62.28 / -0.13 (-0.21%) 02/25/21 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.6% 02/18/21 State Street appoints Theresa McLaughlin as global CMO 01/14/21 TD Bank Group to acquire Wells Fargo's Canadian Direct Equipment Finance unit 12/03/20 Toronto-Dominion reports Common Equity Tier 1 Capital ratio 13.1% USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/11/21 U.S. Bancorp division partners with Built for online construction loans 01/20/21 U.S. Bancorp sees Q1 NIM down in low single digits 01/20/21 U.S. Bancorp sees mortgage revenue down in Q1 on linked-quarter basis ACN BAC JKHY KEY QTWO SBNY SFNC SNV TBK TD USB ACN Accenture $251.34 / -3.09 (-1.21%) 02/02/21 Berenberg Accenture price target raised to $285 from $258 at Berenberg 01/29/21 Morgan Stanley Morgan Stanley upgrades 'underappreciated' Cognizant to Overweight 01/06/21 BofA Accenture upgraded to Neutral from Underperform at BofA 01/06/21 BofA Accenture upgraded to Neutral from Underperform at BofA BAC Bank of America $36.40 / +0.34 (+0.94%) 02/22/21 Wells Fargo Wells Fargo boosts Bank of America target, sees path to $55 per share 01/26/21 Atlantic Equities Bank of America upgraded to Overweight from Neutral at Atlantic Equities 01/20/21 RBC Capital Bank of America price target raised to $37 from $28 at RBC Capital 01/11/21 Citi Bank of America upgraded to Buy from Neutral at Citi JKHY Jack Henry $150.47 / -1.78 (-1.17%) 02/12/21 Compass Point Jack Henry upgraded to Buy from Neutral at Compass Point 01/11/21 Evercore ISI Jack Henry upgraded to In Line from Underperform at Evercore ISI 12/07/20 Credit Suisse Jack Henry initiated with a Neutral at Credit Suisse 11/09/20 DA Davidson Jack Henry upgraded to Buy from Neutral at DA Davidson KEY KeyCorp $20.38 / -0.25 (-1.21%) 03/03/21 Piper Sandler KeyCorp downgraded to Neutral from Overweight at Piper Sandler 02/17/21 Citi Citi recommends two new U.S. bank pair trades 01/06/21 Deutsche Bank KeyCorp price target raised to $18 from $14 at Deutsche Bank 01/04/21 Barclays KeyCorp price target raised to $20 from $15 at Barclays QTWO Q2 Holdings $109.35 / -4.62 (-4.05%) 02/23/21 Canaccord Q2 Holdings price target raised to $155 from $116 at Canaccord 02/19/21 Truist Q2 Holdings price target raised to $164 from $120 at Truist 02/19/21 Wells Fargo Q2 Holdings price target raised to $160 from $115 at Wells Fargo 02/19/21 KeyBanc Q2 Holdings price target raised to $155 from $140 at KeyBanc SBNY Signature Bank $215.40 / -6.46 (-2.91%) 03/03/21 UBS Signature Bank price target raised to $275 from $190 at UBS 02/11/21 Wedbush Signature Bank price target raised to $280 from $210 at Wedbush 02/09/21 JPMorgan JPMorgan boosts Signature Bank target to $250, adds to Focus List 01/26/21 Credit Suisse Signature Bank price target raised to $180 from $120 at Credit Suisse SFNC Simmons First National $31.25 / +0.42 (+1.36%) 10/20/20 Fly Intel: Top five analyst downgrades 10/20/20 DA Davidson Simmons First National downgraded to Neutral from Buy at DA Davidson 06/17/20 Raymond James Simmons First National upgraded to Outperform from Market Perform at Raymond James 06/17/20 Raymond James Simmons First National upgraded to Outperform from Market Perform at Raymond James SNV Synovus $43.99 / -0.2 (-0.45%) 01/08/21 Piper Sandler Synovus price target raised to $40 from $37 at Piper Sandler 01/07/21 Jefferies Synovus upgraded to Buy with $40 price target at Jefferies 01/07/21 Jefferies Synovus upgraded to Buy from Hold at Jefferies 12/11/20 RBC Capital Synovus upgraded to Outperform on better credit and capital view at RBC Capital TBK Triumph Bancorp $83.90 / +2.28 (+2.79%) 08:50 Today B. Riley Securities Triumph Bancorp price target raised to $85 from $48 at B. Riley Securities 01/07/21 B. Riley Securities Triumph Bancorp price target raised to $48 from $42 at B. Riley Securities 11/12/20 Fly Intel: Top five analyst downgrades 11/12/20 Keefe Bruyette Triumph Bancorp downgraded after 74% rally at Keefe Bruyette TD Toronto-Dominion $62.28 / -0.13 (-0.21%) 03/01/21 Desjardins Toronto-Dominion price target raised to C$83 from C$79 at Desjardins 02/26/21 Canaccord Toronto-Dominion price target raised to C$83 from C$77.50 at Canaccord 02/26/21 BMO Capital Toronto-Dominion price target raised to C$82 from C$75 at BMO Capital 02/26/21 RBC Capital Toronto-Dominion price target raised to C$82 from C$79 at RBC Capital USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 02/17/21 Citi Citi recommends two new U.S. bank pair trades 01/22/21 Fly Intel: Top five analyst upgrades 01/22/21 Citi U.S. Bancorp upgraded to Buy from Neutral at Citi 01/07/21 Jefferies U.S. Bancorp upgraded to Buy with $58 price target at Jefferies ACN BAC JKHY KEY QTWO SBNY SFNC SNV TBK TD USB ACN Accenture $251.34 / -3.09 (-1.21%) 12/17/20 Accenture raises FY21 GAAP EPS view to $8.17-$8.40 from $7.80-$8.10 12/17/20 Accenture sees Q2 revenue $11.55B-$11.95B, consensus $11.35B 12/17/20 Accenture raises FY21 adj. EPS view to $8.02-$8.25, consensus $8.05 12/17/20 Accenture reports Q1 adjusted EPS $2.17, consensus $2.05 BAC Bank of America $36.40 / +0.34 (+0.94%) 01/19/21 Bank of America reports Q4 EPS 59c, consensus 55c 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Bank of America reports deposits rose $320B, or 23%, to $1.7T 10/14/20 Bank of America reports Q3 EPS 51c, consensus 49c JKHY Jack Henry $150.47 / -1.78 (-1.17%) 02/08/21 Jack Henry sees FY21 GAAP EPS $3.85-$3.90, consensus $3.80 02/08/21 Jack Henry reports Q2 GAAP EPS 94c, consensus 87c 02/08/21 Notable companies reporting after market close 11/04/20 Jack Henry reports Q1 EPS $1.19, consensus $1.05 KEY KeyCorp $20.38 / -0.25 (-1.21%) 01/21/21 KeyCorp reports Q4 EPS 56c, consensus 43c 10/21/20 KeyCorp reports Q3 EPS 41c, consensus 37c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open QTWO Q2 Holdings $109.35 / -4.62 (-4.05%) 02/17/21 Q2 Holdings sees Q1 revenue $114.6M-$116.1M, consensus $111.86M 02/17/21 Q2 Holdings sees FY21 revenue $488M-$491M, consensus $488.83M 02/17/21 Q2 Holdings reports Q4 adjusted EPS 2c, consensus 5c 11/04/20 Q2 Holdings ups FY20 revenue view to $402.5M-$404.5M from $398.5M-$402.5M SBNY Signature Bank $215.40 / -6.46 (-2.91%) 01/21/21 Signature Bank reports Q4 EPS $3.26, consensus $2.89 10/20/20 Signature Bank reports Q3 EPS 2.62, consensus $2.76 SFNC Simmons First National $31.25 / +0.42 (+1.36%) 01/26/21 Simmons First National reports Q4 core EPS 57c, consenus 39c 10/19/20 Simmons First National reports Q3 core EPS 63c, consensus 40c SNV Synovus $43.99 / -0.2 (-0.45%) 01/26/21 Synovus reports Q4 adjusted EPS $1.08, consensus 80c 10/20/20 Synovus reports Q3 adjusted EPS 89c, consensus 52c TBK Triumph Bancorp $83.90 / +2.28 (+2.79%) 01/21/21 Triumph Bancorp reports Q4 EPS $1.25, consensus 82c 10/19/20 Triumph Bancorp reports Q3 adj. EPS 91c, consensus 49c TD Toronto-Dominion $62.28 / -0.13 (-0.21%) 02/25/21 Toronto-Dominion reports Q1 adjusted EPS C$1.83 vs. C$1.66 last year 12/03/20 Toronto-Dominion reports Q4 adjusted EPS C$1.60 vs. C$1.59 last year USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 01/20/21 U.S. Bancorp reports Q4 EPS 95c, consensus 95c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/14/20 U.S. Bancorp reports Q3 diluted EPS 99c, consensus 91c 05 Feb 13 May BAC KEY SBNY SNV TD USB BAC Bank of America $36.40 / +0.34 (+0.94%) 02/26/21 BofA, JPMorgan give U.S. employees PTO for COVID-19 vaccinations, Reuters says 02/20/21 Bank stocks still have room to run, Barron's says 02/15/21 Citi, Bank of America cut CEO pay, WSJ reports 01/22/21 Bank of America to pay bonuses for work during the pandemic, CNBC reports KEY KeyCorp $20.38 / -0.25 (-1.21%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open SBNY Signature Bank $215.40 / -6.46 (-2.91%) 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 01/12/21 Deutsche Bank won't do future business with Trump, NY Times reports SNV Synovus $43.99 / -0.2 (-0.45%) 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says TD Toronto-Dominion $62.28 / -0.13 (-0.21%) 01/29/21 TD customers hit with fradulent DoorDash charges, CBC reports USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 11/25/20 Bank of America rumors of flat bonus pool rattles traders, Bloomberg says 09/29/20 Citi's McGuire meets with banking leaders over likely NYC mayoral run, CNBC says 09/17/20 Fed mulls extension of bank dividend restrictions, Bloomberg says ACN BAC JKHY KEY USB ACN Accenture $251.34 / -3.09 (-1.21%) 12/17/20 Fly Intel: Pre-market Movers 09/24/20 Fly Intel: Pre-market Movers 09/23/20 Tesla upgrade, Apple downgrade among today's top calls on Wall Street BAC Bank of America $36.40 / +0.34 (+0.94%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers JKHY Jack Henry $150.47 / -1.78 (-1.17%) 02/08/21 Fly Intel: After-Hours Movers 11/04/20 Fly Intel: After-Hours Movers KEY KeyCorp $20.38 / -0.25 (-1.21%) 01/21/21 Fly Intel: Pre-market Movers 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 00:00 Today Bank and Tech Pop Up Virtual Conference 03/15/21 Virtual Atlanta and Texas Bank Summit 03/18/21 Accenture - ACN 04/15/21 Bank of America - BAC 04/15/21 U.S. Bancorp - USB 04/20/21 KeyCorp - KEY ACN BAC USB ACN Accenture $251.34 / -3.09 (-1.21%) 01/20/21 Largest borrow rate increases among liquid names 12/17/20 Early notable gainers among liquid option names on December 17th 09/24/20 Unusually active option classes on open September 24th BAC Bank of America $36.40 / +0.34 (+0.94%) 08:00 Today Bank of America call buyer realizes 16% same-day gains 02/16/21 Bank of America call volume above normal and directionally bullish 02/09/21 Unusual call flow in option market yesterday 01/13/21 Notable open interest changes for January 13th USB U.S. Bancorp $51.00 / -0.16 (-0.31%) 02/25/21 US Bancorp put volume heavy and directionally bearish 01/04/21 US Bancorp put volume heavy and directionally bearish 12/02/20 US Bancorp put volume heavy and directionally bearish 09/14/20 US Bancorp call volume above normal and directionally bullish
Options	Pure Storage put volume heavy and directionally bearish » 10:35 03/04/21 03/04 10:35 03/04/21 10:35 PSTG Pure Storage $20.50 / -1.4 (-6.39%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options PSTG Pure Storage $20.50 / -1.4 (-6.39%) 02/16/21 Pure Storage, Komprise extend data management partnership 01/05/21 Pure Storage appoints Ajay Singh as Chief Product Officer 01/04/21 Pure Storage up 4% in early trading following 'uncooked alert' from Betaville 12/09/20 Pure Storage up 4% after M&A blog issues 'uncooked alert' regarding rumor PSTG Pure Storage $20.50 / -1.4 (-6.39%) 02/25/21 KeyBanc Pure Storage price target raised to $32 from $23 at KeyBanc 02/25/21 Lake Street Pure Storage price target raised to $29 from $22 at Lake Street 02/25/21 Northland Pure Storage downgraded to Market Perform from Outperform at Northland 02/25/21 Cowen Pure Storage price target raised to $30 from $22 at Cowen PSTG Pure Storage $20.50 / -1.4 (-6.39%) 02/24/21 Pure Storage sees FY22 revenue growth 14%-15%, consensus $1.89B 02/24/21 Pure Storage sees Q1 revenue $405M, consensus $390.81M 02/24/21 Pure Storage reports Q4 non-GAAP EPS 13c, consensus 9c 02/24/21 Notable companies reporting after market close PSTG Pure Storage $20.50 / -1.4 (-6.39%) 02/24/21 Fly Intel: After-Hours Movers 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/24/20 Fly Intel: After-Hours Movers PSTG Pure Storage $20.50 / -1.4 (-6.39%) 02/03/21 Pure Storage call volume above normal and directionally bullish 12/23/20 Pure Storage call volume above normal and directionally bullish 12/18/20 Pure Storage call volume above normal and directionally bullish 12/09/20 Pure Storage call volume above normal and directionally bullish
Syndicate	InnovAge indicated to open at $27.30, IPO priced at $21 » 10:31 03/04/21 03/04 10:31 03/04/21 10:31 INNV InnovAge $0.00 / + (+0.00%) InnovAge (INNV) priced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate 04 Mar
General news	EIA natural gas storage change for week ending February 26 » 10:30 03/04/21 03/04 10:30 03/04/21 10:30 USO United States Oil Fund $41.87 / +0.73 (+1.77%) Gas inventories were… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals Options USO United States Oil Fund $41.87 / +0.73 (+1.77%) 12/29/20 API crude inventories for week of December 21 USO United States Oil Fund $41.87 / +0.73 (+1.77%) 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 01/05/21 OPEC+ reaches deal to hold oil output broadly steady, Bloomberg says 12/03/20 OPEC+ agrees on modest oil output increase from January, Reuters says 11/30/20 OPEC reaches broad consensus on oil cut extension, Reuters says USO United States Oil Fund $41.87 / +0.73 (+1.77%) 01/05/21 Unusually active option classes on open January 5th 12/21/20 Unusually active option classes on open December 21st 12/10/20 Unusually active option classes on open December 10th 11/25/20 Unusually active option classes on open November 25th
General news	Treasury Action: a bid tone is emerging in Treasuries » 10:30 03/04/21 03/04 10:30 03/04/21 10:30 Treasury Action: a bid… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Downgrade	Five Prime downgraded to Equal Weight from Overweight at Wells Fargo » 10:29 03/04/21 03/04 10:29 03/04/21 10:29 FPRX Five Prime $37.94 / +16.72 (+78.79%) Wells Fargo analyst Nick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options FPRX Five Prime $37.94 / +16.72 (+78.79%) 09:00 Today Five Prime trading resumes 08:35 Today Amgen to acquire Five Prime for $38.00 per share in cash 08:32 Today Amgen to acquire Five Prime for $38.00 per share in cash, or $1.9B 08:30 Today Amgen to acquire Five Prime for $1.9B in cash FPRX Five Prime $37.94 / +16.72 (+78.79%) 10:22 Today Wells Fargo Five Prime downgraded to Equal Weight from Overweight at Wells Fargo 11/16/20 JPMorgan Zai Lab price target raised to $111 from $101 at JPMorgan 11/11/20 Fly Intel: Top five analyst upgrades 11/11/20 Wells Fargo Five Prime upgraded to Overweight at Wells Fargo after bemarituzumab data FPRX Five Prime $37.94 / +16.72 (+78.79%) 11/03/20 Five Prime reports Q3 EPS (74c), consensus (60c) 13 Nov FPRX Five Prime $37.94 / +16.72 (+78.79%) 09:03 Today Fly Intel: Pre-market Movers 01/15/21 Fly Intel: Pre-market Movers 11/12/20 Fly Intel: Wall Street's top stories for Thursday 11/12/20 Fly Intel: Wall Street's top stories at midday 03/02/21 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/10/21 Five Prime - FPRX FPRX Five Prime $37.94 / +16.72 (+78.79%) 11/12/20 Unusually active option classes on open November 12th
Options	Pfizer call volume above normal and directionally bullish » 10:25 03/04/21 03/04 10:25 03/04/21 10:25 PFE Pfizer $34.96 / +0.58 (+1.69%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $34.96 / +0.58 (+1.69%) 03/03/21 FDA expands approval of Pfizer's Lorbrena 03/02/21 Strata Oncology starts trial with Pfizer as partner 03/01/21 Flowserve supports Pfizer in production of COVID-19 vaccine 02/26/21 Pfizer: EMA accepts MAA for 20-valent pneumococcal conjugate vaccine candidate PFE Pfizer $34.96 / +0.58 (+1.69%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/03/21 Mizuho Pfizer price target lowered to $42 from $44 at Mizuho PFE Pfizer $34.96 / +0.58 (+1.69%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open PFE Pfizer $34.96 / +0.58 (+1.69%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/19/21 Pfizer to use additional capacity to boost vaccine output, Bloomberg says 02/19/21 BioNTech, Pfizer vaccine 85% effective after first dose, FT reports PFE Pfizer $34.96 / +0.58 (+1.69%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 03/24/21 Arthritis Advisory Committee and Drug Safety & Risk Mgmt Committee Meeting 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 03/05/21 Pfizer PFE Pfizer $34.96 / +0.58 (+1.69%) 01/29/21 Unusually active option classes on open January 29th 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th
General news	FX Action: The dollar » 10:25 03/04/21 03/04 10:25 03/04/21 10:25 FX Action: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	Morgan Stanley equity strategist to hold analyst/industry conference call » 10:25 03/04/21 03/04 10:25 03/04/21 10:25 US Equity Strategist… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	First Foundation participates in a conference call with Wedbush » 10:25 03/04/21 03/04 10:25 03/04/21 10:25 FFWM First Foundation $24.15 / +0.61 (+2.59%) Mid-Cap Banks Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events FFWM First Foundation $24.15 / +0.61 (+2.59%) 01/07/21 B. Riley Securities First Foundation price target raised to $26 from $25 at B. Riley Securities 12/16/20 B. Riley Securities First Foundation price target raised to $25 from $23 at B. Riley Securities 12/04/20 B. Riley Securities First Foundation price target raised to $23 from $21 at B. Riley Securities 07/22/20 B. Riley FBR First Foundation price target raised to $21 from $19 at B. Riley FBR FFWM First Foundation $24.15 / +0.61 (+2.59%) 01/26/21 First Foundation reports Q4 EPS 50c, consensus 44c 10/27/20 First Foundation reports Q3 EPS 69c, consensus 50c 11:00 Today First Foundation - FFWM

Conference/Events	LCI Industries participates in a conference call hosted by CL King » 10:22 03/04/21 03/04 10:22 03/04/21 10:22 LCII LCI Industries $134.14 / -2.68 (-1.96%) CL King holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LCII LCI Industries $134.14 / -2.68 (-1.96%) 02/25/21 Lippert promotes Eileen Pruitt to Deputy CHRO, Senior Legal Counsel 12/22/20 LCI Industries CEO sells 10,000 common shares 10/06/20 LCI Industries, Walk West launch Ablr joint venture LCII LCI Industries $134.14 / -2.68 (-1.96%) 09/25/20 Northcoast LCI Industries upgraded to Buy from Neutral at Northcoast 09/22/20 CJS Securities LCI Industries upgraded to Outperform from Market Perform at CJS Securities 07/15/20 CL King LCI Industries price target raised to $134 from $121 at CL King 07/06/20 Citi LCI Industries initiated with a Neutral at Citi LCII LCI Industries $134.14 / -2.68 (-1.96%) 02/09/21 LCI Industries reports Q4 EPS $1.92, consensus $1.79 11/02/20 LCI Industries reports Q3 adj. EPS $2.72, consensus $2.42 LCII LCI Industries $134.14 / -2.68 (-1.96%) 02/03/21 Fly Intel: After-Hours Movers 00:00 Today LCI Industries - LCII
Technical Analysis	NASDAQ market internals summary » 10:17 03/04/21 03/04 10:17 03/04/21 10:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 03/03/21 NASDAQ market internals summary 03/03/21 NASDAQ market internals summary 03/03/21 NASDAQ market internals summary 03/03/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 10:16 03/04/21 03/04 10:16 03/04/21 10:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 03/03/21 NYSE market internals summary 03/03/21 NYSE market internals summary 03/03/21 NYSE market internals summary 03/03/21 NYSE market internals summary
Options	GSX Techedu put volume heavy and directionally bearish » 10:15 03/04/21 03/04 10:15 03/04/21 10:15 GSX GSX Techedu $80.89 / -6.115 (-7.03%) Bearish flow noted in GSX… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSX GSX Techedu $80.89 / -6.115 (-7.03%) 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% 12/07/20 GSX Techedu rises 15.3% 11/23/20 GSX 'as close as possible' to being proven fraud before delisting, Block says GSX GSX Techedu $80.89 / -6.115 (-7.03%) 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan 01/29/21 GSX Techedu downgraded to Sell from Neutral at China Merchants 01/28/21 Goldman Sachs GSX Techedu downgraded to Sell from Neutral at Goldman Sachs 12/17/20 Fly Intel: Top five analyst downgrades GSX GSX Techedu $80.89 / -6.115 (-7.03%) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) GSX GSX Techedu $80.89 / -6.115 (-7.03%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says GSX GSX Techedu $80.89 / -6.115 (-7.03%) 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 11/20/20 Fly Intel: Wall Street's top stories for Friday 03/05/21 GSX Techedu - GSX GSX GSX Techedu $80.89 / -6.115 (-7.03%) 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish 12/28/20 GSX Techedu put volume heavy and directionally bearish 12/22/20 GSX Techedu put volume heavy and directionally bearish
General news	U.S. factory orders climbed 2.6% in January » 10:15 03/04/21 03/04 10:15 03/04/21 10:15 U.S. factory orders… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

General news	Week of 2/26 EIA Natural Gas Report to be released at 10:30 10:15 03/04/21 03/04 10:15 03/04/21 10:15
Syndicate	Twin Ridge Capital Acquisition opens at $9.98, IPO priced at $10 » 10:14 03/04/21 03/04 10:14 03/04/21 10:14 TRCA Twin Ridge Capital Acquisition $0.00 / + (+0.00%) Twin Ridge Capital… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	Factory Orders Month over Month data reported » 10:14 03/04/21 03/04 10:14 03/04/21 10:14 January Factory Orders… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Trident Acquisitions Corporation (Units) trading resumes 10:14 03/04/21 03/04 10:14 03/04/21 10:14
Hot Stocks	Trident Acquisitions Corporation (Units) trading halted, volatility trading pause 10:09 03/04/21 03/04 10:09 03/04/21 10:09

Upgrade	BioMarin assumed at Buy from Neutral at Guggenheim » 10:08 03/04/21 03/04 10:08 03/04/21 10:08 BMRN BioMarin $75.38 / -0.65 (-0.85%) Guggenheim analyst Debjit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMRN BioMarin $75.38 / -0.65 (-0.85%) 03/03/21 BioMarin completes enrollment in Phase 2 study of vosoritide 01/10/21 BioMarin announces topline results from ongoing global Phase 3 GENEr8-1 study 12/21/20 BioMarin reports results of Phase 3 extension study of vosoritide 11/17/20 BioMarin and Deep Genomics enter into preclinical collaboration BMRN BioMarin $75.38 / -0.65 (-0.85%) 03/01/21 Evercore ISI BioMarin upgraded to Outperform from In Line at Evercore ISI 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list 01/11/21 Baird BioMarin price target raised to $110 from $100 at Baird 12/21/20 Piper Sandler BioMarin data today should ease approvability concerns, says Piper Sandler BMRN BioMarin $75.38 / -0.65 (-0.85%) 02/25/21 BioMarin sees FY21 revenue $1.75B-$1.85B, consensus $1.91B 02/25/21 BioMarin reports Q4 EPS 12c, consensus (19c) 11/05/20 BioMarin sees FY20 revenue $1.81B-$1.87B, consensus $1.86B 11/05/20 BioMarin reports Q3 adjusted EPS $4.01, consensus $1.29 BMRN BioMarin $75.38 / -0.65 (-0.85%) 02/02/21 Amicus, BioMarin speculated by Dealreporter as possible Vertex targets BMRN BioMarin $75.38 / -0.65 (-0.85%) 02/25/21 Fly Intel: After-Hours Movers 03/02/21 41st Annual Healthcare Virtual Conference 08/20/21 PDUFA Date for Vosoritide BMRN BioMarin $75.38 / -0.65 (-0.85%) 09/18/20 BioMarin call volume above normal and directionally bullish
Options	Palantir Technologies call volume above normal and directionally bullish » 10:05 03/04/21 03/04 10:05 03/04/21 10:05 PLTR Palantir $24.35 / +0.75 (+3.18%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PLTR Palantir $24.35 / +0.75 (+3.18%) 09:19 Today Tanger Factory up 25% in pre-market trading amid WallStreetBets mentions 02/18/21 Palantir, Akin Gump collaborate on legal digital service platform 02/16/21 Peter Thiel reports 6.6% passive stake in Palantir 02/08/21 IBM, Palantir announce new partnership PLTR Palantir $24.35 / +0.75 (+3.18%) 02/17/21 Fly Intel: Top five analyst upgrades 02/17/21 RBC Capital Palantir price target raised to $27 from $15 at RBC Capital 02/17/21 Jefferies Palantir 'a highly unique story for long-term investors,' says Jefferies 02/17/21 Morgan Stanley Palantir price target raised to $19 from $17 at Morgan Stanley PLTR Palantir $24.35 / +0.75 (+3.18%) 02/16/21 Palantir sees FY21 revenue growth greater than 30% 02/16/21 Palantir sees Q1 revenue growth 45% 02/16/21 Palantir reports Q4 EPS (8c), consensus 2c 11/12/20 Palantir sees Q4 revenue $299M-$301M, consensus $296.03M PLTR Palantir $24.35 / +0.75 (+3.18%) 01/13/21 Pentagon cybersecurity project slowed by flaws, Bloomberg says 11/27/20 Citron shorting Palantir, sees $20 stock by end of 2020 11/17/20 Soros reveals stake in Palantir, but plans to sell it, CNN Business reports 11/06/20 Hedgeye adds Palantir to best idea short list, Bloomberg says PLTR Palantir $24.35 / +0.75 (+3.18%) 03/01/21 Fly Insider: Cannae Holdings, Palantir among week's notable inside trades 02/28/21 Opening Day: Coinbase files to go public 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday PLTR Palantir $24.35 / +0.75 (+3.18%) 03/02/21 Notable open interest changes for March 2nd 03/01/21 Notable open interest changes for March 1st 02/26/21 Notable open interest changes for February 26th 02/22/21 Notable open interest changes for February 22nd
Conference/Events	Senate Banking, Housing & Urban Affairs Committee to hold a virtual hearing » 10:05 03/04/21 03/04 10:05 03/04/21 10:05 The Committee holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
On The Fly	Snowflake, Qualcomm upgrades among today's top calls on Wall Street » 10:04 03/04/21 03/04 10:04 03/04/21 10:04 SNOW Snowflake $246.30 / -0.58 (-0.23%) , QCOM Qualcomm $131.86 / +0.26 (+0.20%) , QS QuantumScape $47.33 / -1.11 (-2.29%) , BMBL Bumble $62.30 / +0.42 (+0.68%) , ANTM Anthem $323.40 / +8.73 (+2.77%) Check out today's top… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SNOW QCOM QS ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 03/03/21 Snowflake CEO sees improving operating efficiency 03/03/21 Snowflake reports Q4 net revenue retention rate of 168% vs. 162% in Q3 03/03/21 Snowflake falls about 4% to $237 after Q4 earnings miss 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal QCOM Qualcomm $131.86 / +0.26 (+0.20%) 03/03/21 Lantronix announces Mobile HDK featuring Qualcomm Snapdragon 888 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 02/09/21 Globalstar announces inclusion of Band n53 in Qualcomm's X65 modem 02/03/21 Qualcomm down 7% to $151.01 after Q1 earnings, Q2 outlook QS QuantumScape $47.33 / -1.11 (-2.29%) 02/17/21 QuantumScape rises 11.3% 02/17/21 QuantumScape rises 10.8% 01/31/21 Fly Intel: Top five weekend stock stories 01/14/21 QuantumScape names Jens Wiese to board, filling second Volkswagen seat ANTM Anthem $323.40 / +8.73 (+2.77%) 02/02/21 Anthem in pact to acquire InnovaCare Health's Puerto Rico-based subsidiaries 01/27/21 Anthem sees FY21 operating cash flow greater than $5.7B 01/27/21 Anthem sees FY21 medical membership 44.1M-44.7M 01/27/21 Anthem raises quarterly divdend to $1.13 from 95c per share SNOW QCOM QS BMBL ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 09:55 Today Fly Intel: Top five analyst upgrades 09:19 Today Goldman Sachs Snowflake price target lowered to $270 from $310 at Goldman Sachs 08:48 Today Credit Suisse Snowflake price target lowered to $275 from $310 at Credit Suisse 08:09 Today Jefferies Snowflake remains 'fully valued' despite 'incredible numbers,' says Jefferies QCOM Qualcomm $131.86 / +0.26 (+0.20%) 09:55 Today Fly Intel: Top five analyst upgrades 07:55 Today JPMorgan Qualcomm price target lowered to $170 from $185 at JPMorgan 06:01 Today Piper Sandler Qualcomm upgraded to Overweight from Neutral at Piper Sandler 02/10/21 JPMorgan China mobile shipments data point to 'robust' Apple demand, says JPMorgan QS QuantumScape $47.33 / -1.11 (-2.29%) 06:35 Today Baird QuantumScape initiated with a Neutral at Baird 02/11/21 Morgan Stanley QuantumScape initiated with an Overweight at Morgan Stanley 02/04/21 Goldman Sachs QuantumScape initiated with a Neutral at Goldman Sachs 11/30/20 Fly Intel: Top five analyst initiations BMBL Bumble $62.30 / +0.42 (+0.68%) 09:55 Today Fly Intel: Top five analyst initiations 06:19 Today Susquehanna Bumble initiated with a Positive, $78 price target at Susquehanna 06:05 Today Susquehanna Bumble initiated with a Positive at Susquehanna 03/02/21 Benchmark Benchmark sees 'hidden asset' inside Momo, ups target to $32 ANTM Anthem $323.40 / +8.73 (+2.77%) 07:09 Today Truist Anthem upgraded to Buy from Hold at Truist 01/28/21 Credit Suisse Anthem price target lowered to $382 from $389 at Credit Suisse 01/28/21 Stephens Anthem price target lowered to $340 from $350 at Stephens 01/26/21 Cowen Anthem price target raised to $360 from $330 at Cowen SNOW QCOM ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 03/03/21 Snowflake sees FY22 product revenue $1.00B-$1.02B, consensus $1.10B 03/03/21 Snowflake sees Q1 product revenue revenue $195M-$200M, consensus $213.06M. 03/03/21 Snowflake reports Q4 EPS (70c), consensus (17c) 03/03/21 Notable companies reporting after market close QCOM Qualcomm $131.86 / +0.26 (+0.20%) 02/03/21 Qualcomm sees Q2 EPS $1.55-$1.75, consensus $1.57 02/03/21 Qualcomm reports Q1 EPS $2.17, consensus $2.10 02/03/21 Notable companies reporting after market close 11/04/20 Qualcomm sees Q1 adjusted EPS $1.95-$2.15, consensus $1.68 ANTM Anthem $323.40 / +8.73 (+2.77%) 01/27/21 Anthem sees FY21 adjusted EPS greater than $24.50, consensus $25.34 01/27/21 Anthem reports Q4 adjusted EPS $2.54, consensus $2.52 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 11 Feb 16 Sep SNOW QCOM QS ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 09/26/20 Western Digital could have plenty of upside, Barron's says 09/15/20 Snowflake IPO priced at $120 per share, CNBC reports QCOM Qualcomm $131.86 / +0.26 (+0.20%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/12/21 FTC opened in-depth investigation of Nvidia's ARM deal, Bloomberg reports 02/12/21 Qualcomm expresses concern over Nvidia's $40B Arm takeover, CNBC reports QS QuantumScape $47.33 / -1.11 (-2.29%) 01/30/21 QuantumScape driven solely by promise, Barron's says 01/04/21 QuantumScape batteries 'small and unproven,' Seeking Alpha contributor says 12/23/20 XL Fleet jumps after Citron puts $60 price target on shares 12/07/20 QuantumScape battery tech could be 'huge' for EVs, Barron's reports ANTM Anthem $323.40 / +8.73 (+2.77%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/31/20 Managed-care stocks, Anthem could rise after vote, Barron's says 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/24/20 Blue Cross Blue Shield group reaches tentative antitrust settlement, WSJ says SNOW QCOM QS BMBL ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 03/03/21 Fly Intel: After-Hours Movers 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 01/03/21 Opening Day: Six IPOs to watch in 2021 12/15/20 Before the Move: Watch Snowflake into lockup expiration QCOM Qualcomm $131.86 / +0.26 (+0.20%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/04/21 Fly Intel: Wall Street's top stories for Thursday QS QuantumScape $47.33 / -1.11 (-2.29%) 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/17/21 QuantumScape jumps on battery technical breakthrough 12/12/20 Charged: Analysts downgrade Tesla, QS battery tech seen as 'huge' for EVs 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns BMBL Bumble $62.30 / +0.42 (+0.68%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut ANTM Anthem $323.40 / +8.73 (+2.77%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/27/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 03/10/21 Bumble - BMBL 03/11/21 Snowflake - SNOW 04/28/21 Qualcomm - QCOM 00:00 Today Qualcomm 03/10/21 Qualcomm Inc. SNOW QCOM QS BMBL ANTM SNOW Snowflake $246.30 / -0.58 (-0.23%) 03/03/21 Snowflake options imply 14.4% move in share price post-earnings 02/09/21 Snowflake call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/07/21 Snowflake call volume above normal and directionally bullish QCOM Qualcomm $131.86 / +0.26 (+0.20%) 12/07/20 Qualcomm call buyer realizes 32% same-day gains 12/04/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Early notable gainers among liquid option names on November 11th QS QuantumScape $47.33 / -1.11 (-2.29%) 02/25/21 Quantumscape call volume above normal and directionally bullish 02/16/21 Quantumscape call buyer realizes 44% same-day gains 02/12/21 Stock-up vol-up in Quantumscape with calls leading puts 7:1 02/12/21 Unusually active option classes on open February 12th BMBL Bumble $62.30 / +0.42 (+0.68%) 02/18/21 Fourteen new option listings and one option delisting on February 18th ANTM Anthem $323.40 / +8.73 (+2.77%) 09:55 Today Early notable gainers among liquid option names on March 4th 02/23/21 Early notable gainers among liquid option names on February 23rd 11/04/20 Early notable gainers among liquid option names on November 4th
Hot Stocks	Azek to build manufacturing facility in Boise, Idaho » 10:02 03/04/21 03/04 10:02 03/04/21 10:02 AZEK Azek $42.85 / -0.17 (-0.40%) The AZEK Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events AZEK Azek $42.85 / -0.17 (-0.40%) 03/03/21 Azek CEO sells 55,000 class A common shares 12/03/20 Azek CEO: We felt really good about the quarter 11/29/20 Fly Intel: Top five weekend stock stories AZEK Azek $42.85 / -0.17 (-0.40%) 02/12/21 B. Riley Securities Azek price target raised to $50 from $48 at B. Riley Securities 02/12/21 Barclays Azek price target raised to $51 from $44 at Barclays 02/12/21 Citi Azek price target raised to $47 from $42 at Citi 01/26/21 RBC Capital Azek price target raised to $50 from $43 at RBC Capital AZEK Azek $42.85 / -0.17 (-0.40%) 02/11/21 Azek sees Q2 revenue growth 13%-15% y/y, consensus $277.33M 02/11/21 Azek raises FY21 sales growth view to 14%-18% from 10%-14%, consensus $1.03B 02/11/21 Azek reports Q1 adjusted EPS 15c, consensus 11c 01/19/21 Azek sees Q1 adjusted EBITDA $46.2M-$51.1M vs. $33.8M last year 22 Jan 11 Sep 12 Jun AZEK Azek $42.85 / -0.17 (-0.40%) 11/28/20 Decking making pandemic bearable, good news for Azek, Barron's says AZEK Azek $42.85 / -0.17 (-0.40%) 12/03/20 Fly Intel: Pre-market Movers 09/08/20 Fly Intel: After-Hours Movers 03/08/21 Azek

Events

Earnings calls, analyst events, roadshows and more

Today at 11:00

30-Year Bond Announcement Government Event
Today at 11:00

3-Month Bill Announcement Government Event
Today at 11:00

6-Month Bill Announcement Government Event
Today at 11:00

3-Year Note Announcement Government Event
Today at 11:00

10-Year Note Announcement Government Event
SD
Today at 11:00

SandRidge Energy - SD Conference Calls
SPKE
Today at 11:00

Spark Energy - SPKE Conference Calls
ASM
Today at 11:00

Avino Silver & Gold Mines - ASM Conference Calls
FFWM
Today at 11:00

First Foundation - FFWM Conference Calls
CULP
Today at 11:00

Culp, Inc. - CULP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50-47.00 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $74.95 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

FDA approves Aurinia's LUPKYNIS for adult patients with active lupus nephritis

TODAY'S FREE FLY STORIES

Get Full Fly Access